ABVC BioPharma, Inc. (ABVC) stock
ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC
$0.96−0.03 (-3.03%)
Close on Nov 12, 2026Market cap $25.59MP/E –Yield –
ABVC BioPharma total assets
Total assets on the balance sheet at the end of each period.
ABVC BioPharma's total assets was $20.30M at Sep 30, 2026. For fiscal 2025 it was $21.82M, up 189.4% from the year before. Over ten years it grew 79.0% a year on average. The highest annual figure on record is $21.82M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.82M | +189.4% |
| FY2024 | Dec 31, 2024 | $7.54M | -3.1% |
| FY2023 | Dec 31, 2023 | $7.78M | -18.7% |
| FY2022 | Dec 31, 2022 | $9.58M | -30.1% |
| FY2021 | Dec 31, 2021 | $13.70M | +18.0% |
| FY2020 | Dec 31, 2020 | $11.61M | +67.5% |
| FY2019 | Dec 31, 2019 | $6.93M | +151.5% |
| FY2017 | Sep 30, 2017 | $2.75M | +1453.3% |
| FY2016 | Sep 30, 2016 | $177.35K | -82.3% |
| FY2015 | Sep 30, 2015 | $1.00M | +1451.9% |
| FY2013 | Sep 30, 2013 | $64.59K | -78.6% |
| FY2012 | Sep 30, 2012 | $302.31K | -18.2% |
| FY2011 | Sep 30, 2011 | $369.40K | +25.7% |
| FY2010 | Sep 30, 2010 | $293.94K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | $20.30M | -4.3% |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $19.40M | +19.5% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $19.73M | +32.6% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $21.82M | +189.4% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $21.21M | +172.8% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $16.24M | +101.9% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $14.88M | +86.5% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $7.54M | -3.1% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $7.78M | -53.1% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $8.04M | -13.7% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $7.98M | -25.7% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $7.78M | -18.7% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $16.59M | +58.3% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $9.32M | -32.4% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $10.73M | -11.0% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $9.58M | -30.1% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $10.48M | -15.2% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $13.78M | +54.1% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $12.07M | +14.6% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $13.70M | +18.0% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $12.35M | +89.2% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $8.94M | +39.1% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $10.53M | +57.9% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $11.61M | +67.5% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $6.53M | -11.8% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | $6.43M | -9.9% |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $6.67M | -10.5% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $6.93M | +151.5% |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | $7.40M | +91852.0% |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | $7.14M | +6610.0% |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | $7.45M | +39858.1% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $2.75M | +1453.3% |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $8.05K | -90.9% |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $106.41K | -87.9% |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $18.65K | -71.3% |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | $177.35K | -82.3% |
| Q3 FY2016CQ2 2016 | Jun 30, 2016 | $88.72K | – |
| Q2 FY2016CQ1 2016 | Mar 31, 2016 | $876.45K | – |
| Q1 FY2016CQ4 2015 | Dec 31, 2015 | $64.91K | – |
| Q4 FY2015CQ3 2015 | Sep 30, 2015 | $1.00M | – |
See a number that looks wrong?